ST
Last reporting period 30 Jun, 2024
Updated 19 Sep, 2024
Last price
—
Market cap $B
0.044
Exchange
XLON - London Stock Exchange
1.5
Last period Current ratio
-10%
Current ratio has decreased in 5 years
What is Current ratio ?
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
See also Shield Therapeutics
Company Analysis
STX.L valuation, rating, competitors, insights and company profile
Eyestock Rating
STX.L financial analysis by Eyestock methodology
Valuation
STX.L valuation using historical relative method
Statements
STX.L Income Statements, Balance Sheet and Cash Flow Statements
Dividends
STX.L dividend yield and annual dividend
Current ratio is the company's ability to repay all its short-term liabilities with available liquid assets. The value of 1.5 is the benchmark for Eyestock Rating calculation.
Shield Therapeutics`s Current ratio for the last twelve months ended 2024-06-30 is 1.5
